Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|October 28, 2009
Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expressionBo Shen, Robert S Smith, Yi-Te Hsu, et al.
Circulation|January 5, 2002
Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemiaPaolo Porcu, Costanza Emanueli, Maria Kapatsoris, et al.
The Journal of Biological Chemistry|November 2, 2002
Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammationAiguo Ni, Hang Yin, Jun Agata, et al.
Experimental Cell Research|January 22, 2016
Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesisPengfei Li, Youming Guo, Grant Bledsoe, et al.
Hypertension (Dallas, Tex. : 1979)|December 31, 2003
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosisChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.
Human Gene Therapy|February 3, 2005
Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survivalChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2003
Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusionKazuo Kato, Hang Yin, Jun Agata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2002
Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemiaRobert S Smith, Kuei-Fu Lin, Jun Agata, et al.
Life Sciences|March 15, 2005
Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarctionRobert S Smith, Jun Agata, Chun-Fang Xia, et al.
Molecular and Cellular Biochemistry|May 14, 2013
Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6Jingmei Zhang, Zhirong Yang, Pengfei Li, et al.
Pageof 11